Evidence map›Paper›PMID 31009467›Full record

ArticlePloS one2019

A DNA aptamer reveals an allosteric site for inhibition in metallo-β-lactamases.

Nazmul H Khan, Anthony A Bui, Yang Xiao, R Bryan Sutton, Robert W Shaw, Benjamin J Wylie, Michael P Latham

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Metallo-ß-lactamases: a review.Molecular biology reports · 2020
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nazmul H KhanDepartment of Chemistry & Biochemistry, Texas Tech University, Lubbock, Texas, United States of America.
Anthony A BuiDepartment of Chemistry & Biochemistry, Texas Tech University, Lubbock, Texas, United States of America.ORCID 0000-0001-7991-9412
Yang XiaoDepartment of Chemistry & Biochemistry, Texas Tech University, Lubbock, Texas, United States of America.
R Bryan SuttonDepartment of Cell Physiology & Molecular Biophysics, Texas Tech University Health Sciences Center, Lubbock, Texas, United States of America.
Robert W ShawDepartment of Chemistry & Biochemistry, Texas Tech University, Lubbock, Texas, United States of America.
Benjamin J WylieDepartment of Chemistry & Biochemistry, Texas Tech University, Lubbock, Texas, United States of America.
Michael P LathamDepartment of Chemistry & Biochemistry, Texas Tech University, Lubbock, Texas, United States of America.ORCID 0000-0002-2209-5798

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
The Purchase of a Liquid Chromatography System to facilitate the high-throughput quantification of lipid-protein interactions and membrane ordering using solid-state NMRR35GM124979 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI Benjamin James Wylie · 2017 to 2026
$3.6M
Human dysferlin and its implications in Limb-Girdle Muscular DystrophyR01AR063634 · NIAMS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI SUTTON, ROGER BRYAN · 2014 to 2018
$1.8M
NIAMS NIH HHS R01 AR063634NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R35 GM124979
6 · The paper itself

Abstract

The hydrolysis of β-lactam antibiotics by β-lactamase enzymes is the most prominent antibiotic resistance mechanism for many pathogenic bacteria. Out of this broad class of enzymes, metallo-β-lactamases are of special clinical interest because of their broad substrate specificities. Several in vitro inhibitors for various metallo-β-lactamases have been reported with no clinical efficacy. Previously, we described a 10-nucleotide single stranded DNA aptamer (10-mer) that inhibits Bacillus cereus 5/B/6 metallo-β-lactamase very effectively. Here, we find that the aptamer shows uncompetitive inhibition of Bacillus cereus 5/B/6 metallo-β-lactamase during cefuroxime hydrolysis. To understand the mechanism of inhibition, we report a 2.5 Å resolution X-ray crystal structure and solution-state NMR analysis of the free enzyme. Chemical shift perturbations were observed in the HSQC spectra for several residues upon titrating with increasing concentrations of the 10-mer. In the X-ray crystal structure, these residues are distal to the active site, suggesting an allosteric mechanism for the aptamer inhibition of the enzyme. HADDOCK molecular docking simulations suggest that the 10-mer docks 26 Å from the active site. We then mutated the three lysine residues in the basic binding patch to glutamine and measured the catalytic activity and inhibition by the 10-mer. No significant inhibition of these mutants was observed by the 10-mer as compared to wild type. Interestingly, mutation of Lys50 (Lys78; according to standard MBL numbering system) resulted in reduced enzymatic activity relative to wild type in the absence of inhibitor, further highlighting an allosteric mechanism for inhibition.

Indexed as

Allosteric SiteAnti-Bacterial AgentsAptamers, NucleotideBacillus cereusbeta-Lactamase Inhibitorsbeta-LactamasesCatalysisCatalytic DomainCrystallography, X-RayKineticsMagnetic Resonance SpectroscopyMolecular Docking SimulationMutagenesis, Site-DirectedProtein BindingSubstrate SpecificityAnti-Bacterial AgentsAptamers, Nucleotidebeta-Lactamase Inhibitorsbeta-Lactamases

Identifiers

PMID31009467
PMCPMC6476477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.